|
|
![]()
|
http://www.medscape.com/viewarticle/463493
Recent Advances in Understanding
the Pathogenesis of Obstructive Sleep Apnea Amy S. Jordan, David P. White, Robert B. Fogel Curr Opin Pulm
Med 9(6):459-464, 2003. © 2003 Lippincott Williams
& Wilkins Posted AbstractPurpose of
review:
The pathogenesis of obstructive sleep apnea (OSA) is incompletely understood.
Historically it was believed that patients with OSA have a small upper airway
(often due to obesity) that is kept patent during wakefulness by the activity
of upper airway dilating muscles. With the reduction in muscle tone at sleep
onset, the airway collapses and causes apnea. While this appears to be the
case for many patients with OSA, other patients show no major airway anatomic
defects or minimal obesity. IntroductionObstructive
sleep apnea (OSA) is a disorder characterized by repetitive upper airway
collapse during sleep that affects approximately 4% of adult men and 2% of
adult women.[1] The pathophysiology of obstructive
sleep apnea is likely multifactorial with
contributions from airway anatomy, the state-dependent control of upper
airway dilator muscles, and ventilatory stability
(Fig. 1). A small or collapsible pharyngeal airway is central to the
pathogenesis of OSA. During wakefulness, the collapsible airway remains
patent due to the high activity of upper airway muscles. However, at sleep
onset, this compensatory activation is reduced or lost resulting in partial
or complete upper airway collapse. Other changes at sleep onset may also
contribute to airway collapse such as the reduction in central respiratory
drive and falling lung volume. During airway obstruction, hypoxemia and hypercapnia develop, which cause a progressive increase
in drive to the respiratory pump and upper airway muscles. However this rarely
results in re-opening of the upper airway unless accompanied by arousal from
sleep. Following arousal, hyperventilation reverses the blood gas disturbance
and correspondingly central drive is reduced. The patient then falls back
asleep and the cycle repeats itself. How the well-identified epidemiological
risk factors such as obesity, older age, and male gender influence these
processes is largely unknown.
Figure 1. Cyclical nature of obstructive sleep
apnea and possible pathophysiologic factors. The sleep
fragmentation and repetitive hypoxemia associated with OSA contribute to the
primary symptoms of the disorder: excessive daytime sleepiness,[2] neurocognitive
impairment,[3, 4] and increased risk for motor vehicle accidents.[5, 6] OSA has also been
associated with adverse cardiovascular consequences such as hypertension.[7-9] Understanding the
pathogenesis of OSA is therefore important such that alternative treatments
and preventions for these adverse outcomes can be identified. Upper Airway AnatomyA number of
previous studies have clearly demonstrated that the pharyngeal airway of the
apnea patient is smaller than that seen in controls.[10-12] In addition, a number
of anatomic structures in the upper airway have been described as being
larger in the apnea patient, including the tongue, parapharyngeal
fat pads, and the lateral walls surrounding the pharyngeal airway.[13] However, it is
unclear whether these changes are of sufficient magnitude to explain disease
pathogenesis, especially as there is substantial overlap in anatomic
structure between OSA patients and controls. Two recent
studies have used anatomic measurements in an attempt to define the mechanism
explaining the increased prevalence of OSA in men. Previous studies have
shown men to have a larger or similar-sized pharyngeal airway as women,[14, 15] a feature that would
not be expected to lead to increased airway collapsibility during sleep. Malhotra et al. [16**] used MRI to examine
anatomic characteristics of the pharyngeal airway in healthy men and women.
This data was then combined with finite element modeling techniques to
estimate the pathophysiologic importance of their
findings. They observed men to have a significantly longer pharyngeal airway
(choanae to epiglottis) than women, even when
corrected for body height. Furthermore, the modeling analysis demonstrated
that increasing airway length is associated with an increase in pharyngeal
collapsibility. In a second
study, Rowley et al.[17*] used endoscopic techniques to measure the cross-sectional area
of the pharyngeal airway during tidal breathing in healthy subjects. They
combined this technique with simultaneous pharyngeal pressure measurements to
assess the compliance of the upper airway. They confirmed that men have a
larger cross-sectional area of the retropalatal
airway than women although this area was not different after correcting for
body surface area. They also reported that the retropalatal
airway was more compliant in men than women (greater change in area during
inspiration) both during wakefulness and sleep. This difference disappeared
after correcting for neck circumference and the authors suggest that the
larger neck circumference in men renders the male airway more compliant.
However, Malhotra et al.'s[16**] observation of a
longer airway in men might explain the greater compliance as well. While both
of these studies represent important advances, further work is clearly
required before the gender difference in apnea susceptibility is completely
understood. Upper Airway MusclesThe
pharyngeal dilator muscles are important in maintaining pharyngeal patency as they oppose the negative collapsing force
developed during inspiration. Furthermore, physiologic data have shown that
airway collapse during sleep in patients with OSA occurs as upper airway
muscle activity falls.[18] Although there are over 20 muscles in the human
pharyngeal airway, the most-studied dilator muscle is the genioglossus. Previous
studies have shown that the genioglossus is more
active in apnea patients during wakefulness (increased EMG) and that at sleep
onset this activity falls to a greater extent than in controls.[19] However during stable
sleep in healthy individuals, genioglossal activity
(GGEMG) is maintained at or above waking levels.[20, 21] The mechanisms behind
this activation remain unclear as previous studies have demonstrated GGEMG to
be much less responsive to stimuli such as negative intrapharyngeal
pressure and changes in arterial blood gases during sleep.[22, 23] Stanchina
et al.[24*] have attempted to shed light on this by examining the
responsiveness of GGEMG to chemical and mechanical stimuli during NREM sleep
in humans. GGEMG was measured under basal conditions and during hypoxia, hypercapnia, and inspiratory
resistive loading. They found that although there was a trend toward higher
GGEMG during hypercapnia, the only statistically
higher muscle activity was seen during the combination of inspiratory
resistive loading and hypercapnia. They conclude
that during stable NREM sleep, the combination of mechanical and chemical
stimuli are much more effective at increasing upper airway muscle activity
than either stimulus alone. However, the muscles are clearly less responsive
when the subject is asleep rather than awake. Two studies
have used the rat to better understand mechanisms controlling genioglossal muscle activity. First, Ryan et al.[25*] performed
neuromuscular blockade in anesthetized, mechanically ventilated rats and
recorded directly from the hypoglossal nerve (which controls genioglossal activation). They found that neuromuscular
blockade led to decreased basal activity in the hypoglossal nerve, as well as
decreased responsiveness to stimuli such as asphyxia and pulses of negative
pressure. These data suggest that basal upper airway muscle activation is
important in determining the output of the motor neuron systems that control
such muscle activity, although the mechanism for this finding is unclear. If
true, raising basal muscle activity might also increase muscle responsiveness
and thus protect against pharyngeal collapse. Second,
Morrison et al.[26] attempted to define the neurochemical
mechanisms controlling genioglossal activity across
natural sleep-wake states using a freely behaving rat model. Most recently,
they assessed the importance of the inhibitory transmitter GABA in
controlling GGEMG. Using a microdialysis probe they
infused bicuculline (a selective GABA antagonist)
at the hypoglossal motor nucleus while recording GGEMG. They found that bicuculline led to an increase in GGEMG during wake and
NREM sleep, but did not prevent the marked inhibition of GGEMG seen during
REM sleep. These findings suggest that GABA exerts a tonic inhibitory
influence in the hypoglossal nucleus during wakefulness and NREM sleep, but
is not responsible for the inhibition of genioglossal
muscle activity during REM sleep. This may suggest a pharmacologic target for
apnea therapy although considerably more work is needed in this area. Ventilatory ControlThe notion
that ventilatory control may be important in the
pathogenesis of OSA is not new, but has not been investigated as actively as
either upper airway anatomy or pharyngeal muscle function. In the early 1980s
Weitzman et al.[27] and Onal and Lopata[28] reported that some tracheostomized
patients with OSA still had cyclical breathing during sleep suggesting that
central respiratory control may be central to the pathogenesis of OSA. More
recently Hudgel et al.[29] and Younes et al.[30] have examined respiratory control
stability and reported that patients with OSA have less stable breathing
patterns than either less severe patients[30] or similarly aged healthy subjects.[29] Although the pathophysiologic importance of these findings is
uncertain, a study by Warner et al.[31] reported that 7 of 9 otherwise healthy
snoring subjects developed obstructive apneas when periodic breathing was
induced with hypoxia, suggesting that respiratory stability may have a causal
role in OSA. Asyali et al.[32] have recently assessed respiratory stability
in patients with OSA and controls in a different manner than previous
investigators.[29, 30] These authors measured the oscillations in ventilation
following tone-induced arousals from sleep in six patients with OSA and five
controls. In contrast to the previous studies,[29, 30] Asyali
et al. found only a trend suggesting a difference in the overall gain
of the respiratory system between the two groups. They did find, however,
that their measures of the chemoreflex component of
the response "exhibited more rapid and underdamped
dynamics" in patients with OSA, providing more evidence that respiratory
control is altered in OSA.[32] There have
also been recent comparisons of respiratory control between the genders aimed
at shedding light on the male predominance in OSA. Zhou et al.[33] previously reported
that women required a greater reduction in CO2 to induce apnea
during sleep than men and that this appeared to be unrelated to female sex
hormones as no menstrual phase effects were observed. This suggests that men
may be more prone than women to periodic oscillations in breathing as less hypocapnia was required to inhibit ventilation in men
than in women. In 2002, the same group investigated possible mechanisms for
this gender difference by studying the effect of 10 to 12 days of exogenous
testosterone on ventilation in the hypocapnic range
in young women [34**]. The authors reported that the PETCO2 at which apnea
occurred was higher (closer to the resting PETCO2) following
testosterone and that the hypocapnic ventilatory response was also increased. It therefore
appears that males, in part due to higher testosterone levels, require
smaller reductions in CO2 to induce apnea/hypopnea. Other FactorsLung VolumeThe influence
of lung volume on the upper airway has been recognized for some time with
changes in airway size[14, 35, 36] and resistance[37, 38] reported with
changing lung volume. In 1990, Begle et al.[37] conducted a study to
investigate the mechanisms of these effects. The authors demonstrated that
raising lung volume reduced pulmonary resistance independent of GGEMG or
chemical stimuli and concluded that caudal traction on the upper airway
structures may have caused this effect. Recently, two additional reports of
the effect of caudal traction on the isolated airway of Vietnamese
pot-bellied pigs were published.[39, 40] Caudal tracheal displacement decreased
the compliance and closing pressure of the pig airway and increased the
maximal airflow during progressive decreases in pressure at the larynx. As
these studies were performed on an isolated airway during general anesthesia
with neuromuscular blockade, these effects are likely due to the mechanical
effects of displacement as opposed to muscle recruitment. The influence
of lung volume on upper airway collapse in humans during sleep has been
minimally studied.[37, 41] However, a recent study indicates that lung volume may be
a determinant of the closing pressure of the airway (PCRIT) in anesthetized
humans.[42] In this study, PCRIT was determined at
three levels of anesthesia while subjects breathed spontaneously. PCRIT became more positive
(ie, the airway was more collapsible) with
increasing depth of anesthesia, despite the fact that GGEMG was low at all
times. The authors concluded that the increase in airway collapsibility was
likely due to the decreased lung volume associated with deeper anesthesia as
the end expiratory esophageal pressure was reduced with lighter anesthesia.
Further studies of the influence of lung volume on airway collapsibility in
humans during sleep are required to determine the role in the pathogenesis of
OSA. Surface TensionFor some time
it has been recognized that the pressure required to open an occluded airway
is greater than that required to collapse it.[43-45] This effect has been
ascribed to surface tension forces in the occluded airway and has propagated
ideas that there may be a role of such forces in the pathogenesis of OSA. In
support of this theory, Jokic et al.[46] originally reported
that topical lubricant applied to the upper airway reduced the severity of
OSA in 10 patients. The role of surface tension in determining upper airway patency has been further examined in two recent papers.[47, 48] Kirkness
et al.[47] assessed the effect of saline and exogenous surfactant on the
airway opening and closing pressures of anesthetized rabbits. Samples of the
liquid lining the airway showed that surface tension was reduced with
surfactant and increased with saline. Correspondingly the opening pressure
increased with saline and decreased with surfactant. Furthermore the closing
pressure was increased with saline but the reduction with surfactant did not
reach statistical significance. Finally,
Morrell et al.[48] reported the effect of exogenous surfactant and saline on
the inspiratory pharyngeal resistance during sleep
of snoring subjects and the severity of sleep apnea in patients with
mild-moderate OSA. In the snoring subjects, surfactant reduced the resistance
at peak pressure while saline did not significantly influence resistance. The
respiratory disturbance index was slightly reduced in patients with OSA after
administration of surfactant. However, sleep quality did not improve. Saline
did not significantly alter the sleep characteristics or disordered breathing
events. Taken together, these two studies suggest that surface tension forces
acting on the upper airway play some role in the pathogenesis of
sleep-disordered breathing although the effect is likely small. Evoked Potentials/Sensory InputsAirway
obstruction during sleep is generally terminated with arousal from sleep. It
is therefore possible that a reduced ability to arouse would influence the
duration of apnea and the likelihood of further obstructive events. OSA
patients have been demonstrated to have a higher arousal threshold to airway
occlusion than normal subjects[49]; however whether this is a cause or effect of
the disorder is unknown. Even if the higher arousal threshold is due to
repeated obstruction and sleep fragmentation, it may still contribute to the
progression of OSA. Two recent studies have examined the mechanisms for the
reduced arousal response seen in OSA patients.[50, 51] Gora et al.[50] reported that the respiratory related evoked
potential (RREP) to mid-inspiratory occlusions in
six patients with untreated mild OSA was similar to six healthy controls
matched for age and body mass index while awake. During sleep the response
was reduced in patients with OSA. This suggests that the increase in arousal
threshold in OSA patients is due to a state-related blunting of the cortical
response to occlusion, rather than abnormal mechanoreceptor function. More recently
Akay et al.[51] have studied the RREP
following brief negative pressure pulses during wakefulness in a group of OSA
patients (n = 14) and control subjects (n = 18). These authors analyzed the
EEG responses differently than Gora et al.[50] and reported that the
global field power was reduced in OSA patients. These authors suggest this
indicates reduced mechanoreceptor sensitivity or stimulation, a conclusion
that differs from that of Gora et al..[50] The differences
between these two studies may be related to the different methods, analysis
techniques, or the number of subjects studied. The role of the reduced
arousal threshold in the pathogenesis of OSA remains unclear. ConclusionThe
pathogenesis of OSA is complex and still incompletely understood. However, it
seemingly involves aspects of upper airway anatomy, pharyngeal muscle
control, and the central control of respiration. Factors such as lung volume,
pharyngeal surface tension, and the ability to arouse from sleep may independently
influence the likelihood of developing OSA. Alternatively they may alter
pharyngeal collapsibility by altering respiratory or pharyngeal muscle
control. The contribution of each of these factors to the pathogenesis of OSA
probably varies between individuals, partially explaining why some patients
are not obese or have minimal anatomic abnormalities. Similarly it is
possible, if not likely, that the male predominance of OSA is explained by
differences in several pathogenic factors. While our knowledge continues to
increase, we still do not have a complete understanding of the pathogenesis
of this highly prevalent condition. ReferencesPapers of
particular interest, published within the annual period of review, have been
highlighted as: * Of special
interest ** Of
outstanding interest
Funding Information This work was
supported by the National Institutes of Health Grants HL60292 and HL48531-10.
Dr. Jordan is a recipient of the Allen and Hanbury's/TSANZ
respiratory fellowship. Dr. Fogel is a recipient of
the National Sleep Foundation's Pickwick
Fellowship. Reprint Address Correspondence
to Amy S. Jordan, PhD, Sleep Disorders Research Program at BIDMC, Brigham and
Women's Hospital, 75 Franc's St., RFB-486 Boston, MA 02115, USA. E-mail: ajordan@rics.bwh.harvard.edu
Amy S. Jordan, David P. White, Robert B. Fogel, Division of Sleep Medicine, Brigham and
Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA |